Scientific evidence indicates that in DRP patients, deterioration in blood flow due to hyperglycemia-related retinal vascular changes, and resultant ischemia in the retina trigger the release of vascular endothelial growth factor (VEGF) and various inflammatory mediators [1,4]. The gene discussed is VEGFA; the disease is Hyperglycemia.